FNY Investment Advisers’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
Other funds holding CCXI
FNY Investment Advisers's CCXI Position: Q4 2022 in Review
FNY Investment Advisers sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 18,100 shares — an estimated $935K sold.
FNY Investment Advisers first reported a position in CCXI in Q3 2022 and held it in 1 quarter. The position peaked at $935K in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.
- FNY Investment Advisers reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
- FNY Investment Advisers sold 18,100 ChemoCentryx, Inc. shares in Q4 2022, an estimated $935K.
- FNY Investment Advisers first reported a position in ChemoCentryx, Inc. in Q3 2022 and held it in 1 quarter.
- FNY Investment Advisers's ChemoCentryx, Inc. position peaked at $935K in Q3 2022.
- 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.
Based on FNY Investment Advisers's 13F filing for Q4 2022, filed 10 Jan 2023.